References
- Carroll B. J., Curtis G. C., Mendels J. Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976; 33: 1051–8
- Carrol B. J., Feinberg M., Greden J. F. A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 1981; 38: 15–22
- Gerner R. H., Gwirtsman. Abnormalities of dexa-methasone suppression test and urinary MHPG in anorexia nervosa. Am J Psychiatry 1981; 138: 650–3
- Raskind M., Peskind E., Rivard M-F, Veith R., Barnes R. Dexamethasone suppression test and Cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 1982; 139: 1468–71
- Baumgartner A., Graf K-J, Kurten I. The dexamethasone suppression test in depression in schizophrenia and during experimental stress. Biol Psychiatry 1985; 20: 675–9
- Wik G., Wiesel F-A, Eneroth P., Sedvall G., Astrom G. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiatr Scand 1986; 74: 161–7
- Catapano F., Monteleone P., Maj M., Kemali D. Dexamethasone suppression test in patients with primary obsessive-compulsive disorder and in healthy controls. Neuropsychobiology 1990; 23: 53–6
- Rybakowski J., Plocka M. Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect. J Affect Disorder 1992; 24: 87–91
- Balldin J., Berggren U., Bokström K., Lindstedt G., Sjöberg J., Wendestam C. Dexamethasone suppression test in alcohol withdrawal: relationship to depression and liver function. Drug Alcohol Depend 1992; 30: 175–9
- åsberg M., Montgomery S. A., Perns C., Schalling D., Sedvall G. A comprehensive psychopathological rating scale. Acta psychiatr Scand 1978; Suppl 271
- Amsterdam J. D., Winokur A., Caroff S. N., Conn J. The dexamethasone suppression test in outpatients with primary affective disorder and healthy control subjects. Am J Psychiatry 1982; 139: 287–91
- Stokes E., Stoll P. M., Koslow S. H., Maas J. W., Davis J. M., Swann A. C. Pretreatment DST and hy-pothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. Arch Gen psychiatry 1984; 41: 257–67
- Carroll BJ. Dexamethasone suppression test. Clin Neuropharmacol 1984; 7: 272–3
- Avery D. H., Osgood T. B., Ishiki D. M., Wilson L. G., Kenny M., Dunner D. L. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder. Am J Psychiatry 1985; 142: 844–8
- Koyama T., Yamashita I. Biological markers of depression: WHO multi-center studies and future perspective. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 791–6